Abstract:Objective: China has the second highest burden of tuberculosis (TB) worldwide, and it is also facing a remarkable increase of Diabetes Mellitus (DM) in the population. DM patients are at high risk of contracting TB and patients with DM–TB comorbidity usually present a relatively poor disease progress. To achieve the goal of TB control on incidence and mortality, it is of great importance to understand the epidemiology of DM–TB comorbidity in the Chinese population. This study aims to understand the prevalence of DM–TB comorbidity in newly diagnosed active TB patients and its demographic distribution in eastern rural China. Methods: A population-based cross-sectional study was carried out in four counties in eastern rural China, two in Jiangsu Province (GDP per capita in 2013: 74699.37 yuan, prevalence of DM: 8.50%) and two in Jiangxi Province (GDP per capita in 2013: 31835.53 yuan, prevalence of DM: 7.63%). All newly diagnosed and registered active TB patients from April 2013 to March 2014 were investigated using a structured questionnaire. Fasting blood glucose levels were tested to screen potential DM patients. Confirmation of diagnosis was made by glycosylated hemoglobin A1c (HbA1C). Results: In total, 1406TB patients from four counties were recruited with 447 (33.8%) being smear-positive TB. The average age of patients was 41 years, and the male to female ratio was 1019 (76.2%) to 319 (23.8%). Overall, 71 DM–TB comorbidity patients were detected; of them 52 (73.24%) were from Jiangsu and 19 (26.76%) from Jiangxi. The prevalence of DM–TB comorbidity was 5.05% of the 1406TB patients. The prevalence of DM–TB in Jiangsu (9.29%) was 4.13 times higher than Jiangxi Province (2.25%, p<0.01). It was found that ethnicity, family history of diabetes, diet habit and Province were associated with the prevalence of DM in TB patients. Compared to patients from Jiangxi Province and Han ethnicity patients, TB patients from Jiangsu Province (60.2% vs. 39.8%, OR: 24.17, 95% CI: 4.94–118.32) and minority patients (1.4% vs. 98.6%, OR: 24.29, 95% CI: 1.69–349.11) had a higher prevalence of DM–TB comorbidity. It was found that patients with a family history of DM had an increased possibility of DM–TB comorbidity (2.6% vs. 97.4%, OR: 6.46, 95% CI: 1.05–39.70), as well as those having a diet consisting of salty food (25.2% vs. 74.8%, OR: 3.41, 95% CI: 1.25–9.29). Conclusion: DM–TB comorbidity is more prevalent in areas with better economic status and higher prevalence of DM. Patients with a DM family history might be at high risk of DM–TB comorbidity. A TB control program should be integrated with DM screening and management program in eastern rural China.

The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study

Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis

Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study From Drug Resistance Surveillance in East China

Quantitative Proteomics Reveals Plasma Protein Profile and Potential Pathways in Pulmonary Tuberculosis Patients with and Without Diabetes.

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China

The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study

The risk factors for tuberculosis patients with diabetes mellitus living in Western China: a retrospective study conducted from 2014 to 2018

Impact of Diabetes on Clinical Presentation and Treatment Outcome of Pulmonary Tuberculosis in Beijing

Ambient air pollutants, diabetes and risk of newly diagnosed drug-resistant tuberculosis

Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM

The effect of diabetes mellitus on tuberculosis in eastern China: A decision‐tree analysis based on a real‐world study

Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China

Multidrug-resistant tuberculosis and diabetes mellitus as a problem of modern medicine

Systematic review and meta‐analysis: Prevalence of diabetes among patients with tuberculosis in China

Demographic Distribution of Diabetes–tuberculosis Comorbidity in Eastern Rural China

Impact Of Diabetes On Diagnostic Delay For Pulmonary Tuberculosis In Beijing

PREVALENCE AND EFFECTIVENESS OF TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS AND DIABETES MELLITUS COMORBIDITY

Screening Diabetes in Tuberculosis Patients in Eastern Rural China: a Community-Based Cross-Sectional Study

Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019

THE RISK OF COMBINED PATHOLOGY OF DIABETES MELLITUS AND TUBERCULOSIS